Evalve

edit

Evalve, Inc. engages in the design, development, manufacture, and marketing of devices that enable the repair of cardiac valves. It provides a non-surgical mitral valve repair system consisting of a steerable guide catheter, a clip delivery system, and an implant device that is used by interventional cardiologists to reduce mitral regurgitation. The company was incorporated in 1999 and is based in Menlo Park, California.

Milestones

edit

• 
  Evalve was acquired by Abbott Labs for $410M. (9/11/09)
  Posted 9/24/09 at 3:23pm
• 
  Evalve received $60M in Series D funding. (11/27/07)
  Posted 9/17/09 at 6:59am

Videos

Screenshots

edit

Sources

1. Studies find Botox cuts migraine days; Abbott to buy Evalve for up to $410M (fiercepharma.com) [edit]
2. Evalve pulls in $60M, heating up heart-valve implant race (venturebeat.com) [edit]